RTI Surgical has unveiled its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.   The rebranding follows a transformative year marked by the acquisitions of Cook Biotech and Collagen Solutions, establishing Evergen as a CDMO offering a comprehensive portfolio of allograft and xenograft biomaterials at scale.   The new identity embodies Evergen’s ...